Quetiapine (Seroquel) maintenance treatment in early onset bipolar spectrum disorders: an open prospective longitudinal study of the effectiveness of quetiapine monotherapy in preventing relapse and minimizing neurocognitive dysfunction among adolescents manifesting bipolar spectrum disorders

Trial Profile

Quetiapine (Seroquel) maintenance treatment in early onset bipolar spectrum disorders: an open prospective longitudinal study of the effectiveness of quetiapine monotherapy in preventing relapse and minimizing neurocognitive dysfunction among adolescents manifesting bipolar spectrum disorders

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2008

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top